24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients

Inclusion Criteria: * ≥ 18 years * Patients with confirmed or newly diagnosed non-alcoholic fatty liver disease (NAFLD),NAFL,NASH * Patients with arterial hypertension, without concomitant liver disease * Patients with overweight or obesity (BMI ≥25) without fatty liver; the latter excluded in advance by current imaging * Patients with chronic hepatitis B, chronic hepatitis C, ethyltoxic liver disease, autoimmune hepatitis, cholestatic liver disease (PBC, PSC) or other chronic hepatopathy; existing liver histology is desirable, but absence is not a criterion for exclusion All patients should be of normal weight (BMI 18.5 - 24.9) and, with the exception of alcoholic liver disease, should not have fatty liver in the imaging. * Patients with chronic inflammatory bowel disease (Crohn's disease, ulcerative colitis, colitis indeterminata) * Healthy controls: no known previous illness, no permanent medication, no fatty liver (excluded in advance by current imaging), normal weight (BMI 18.5 - 24.9). * Present declaration of consent Exclusion Criteria: * Failure to meet the inclusion criteria * A known chronic liver disease that is not described in the above mentioned collectives * Taking drugs that can cause fatty degeneration of the liver (e.g. methotrexate, amiodarone, tamoxifen, etc.) * Circumstances that do not allow the person concerned to assess the nature and extent as well as possible consequences of the clinical trial * Indications that the subject is unlikely to comply w…